Aspect Biosystems
Founded 2013 · 145 employees on LinkedIn · 12 known investors
Find your way into Aspect Biosystems
665 people in our graph share verified history with the Aspect Biosystems team — schools, employers, funds. One of them is your warm intro.
Cristian Pintounlockedknows Tamer Mohamed · together at Unreasonable (overlapped)
×5knows the team · via TED Conferences
×2knows the team · via University of British Columbia
×3knows the team · via Cleveland Clinic
knows the team · via Novo Nordisk
Aspect Biosystems develops bioprinted tissue therapeutics using a platform that combines AI-powered bioprinting, computational design tools, therapeutic cells, and biomaterials to create implantable allogeneic tissues. Its pipeline targets metabolic and endocrine diseases, and it partners with pharma and biotech companies to advance cell therapies to the clinic.
Founders & leadership
Aspect Biosystems was founded in 2013 by Tamer Mohamed, Sam Wadsworth, and Simon Beyer.
TM
Tamer MohamedinFounder & CEOTamer Mohamed is Founder and CEO of Aspect Biosystems, a biotechnology company developing bioprinted tissue therapeutics that combine AI-powered bioprinting, computational design, therapeutic cells, and biomaterials for treatment of metabolic and endocrine diseases.
SW
Sam WadsworthinCo-founder & Chief Scientific OfficerCo-founder and Chief Scientific Officer of Aspect Biosystems, a biotechnology company that uses 3D bioprinting to develop implantable tissue-based cell therapies for metabolic and endocrine diseases.
SB
Simon BeyerinCo-founder & Chief Technology Officer
LP
Leela ParisinChief Technical Operations Officer
MS
Mike ScottinChief Development OfficerMike Scott is Chief Development Officer at Aspect Biosystems and has held multiple leadership roles in medical device and cell therapy development at companies including Novo Nordisk, BlueRock, ViaCyte, Edwards Lifesciences, and Orqis Medical, where he oversaw product development for treatments targeting Parkinson's disease, diabetes, heart failure, and eye diseases.
RS
Ray SmithinChief Financial Officer
Investors · 12
Angel ForumVancouvervia Irene Dorsman · inferred
Civilization Ventures Management, LlcTiburon · $1M – $10M
InBC Investment Corp.British Columbia · $3M – $10M
JDRF T1D FundBoston
Page One VenturesSilicon Valley
Pallasite VenturesVancouver · $100K – $1.5M
Pangaea Ventures Us Inc.Vancouver · $500K – $1.5M
Radical VenturesToronto · $1M – $25M
Relentless Pursuit PartnersVancouver
Rising TidePacifica
6 Dimensions CapitalreportedGrand Cayman
Dimension CapitalreportedSan Francisco · $1M – $10M
Competitors · 3
by search overlap
Fortis Life Sciences8 shared keywordsFortis Life Sciences develops and manufactures Bethyl-branded ELISA kits and related reagents, buffers, and antibodies for detecting target proteins in research and diagnostic applications. The kits cover human and veterinary targets and are made in the USA using the company's own antibodies.
PrintBio8 shared keywordsPrintBio manufactures 3D-printed bioresorbable surgical meshes designed for hernia repair and soft tissue support. The company serves surgeons and hospitals seeking customizable mesh solutions that combine stability and flexibility while reducing infection risk.
Aspect8 shared keywordsAspect provides workforce engagement management (WEM) software for enterprise teams, offering forecasting, scheduling, and performance management capabilities.
Companies competing with Aspect Biosystems for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Aspect Biosystems do?
- Aspect Biosystems develops bioprinted tissue therapeutics using a platform that combines AI-powered bioprinting, computational design tools, therapeutic cells, and biomaterials to create implantable allogeneic tissues. Its pipeline targets metabolic and endocrine diseases, and it partners with pharma and biotech companies to advance cell therapies to the clinic.
- Who founded Aspect Biosystems?
- Aspect Biosystems was founded by Tamer Mohamed, Sam Wadsworth, Simon Beyer in 2013.
- Who are Aspect Biosystems's investors?
- Aspect Biosystems's investors include Angel Forum, Civilization Ventures Management, Llc, InBC Investment Corp., JDRF T1D Fund, Page One Ventures, Pallasite Ventures, Pangaea Ventures Us Inc., Radical Ventures and 4 more.